Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Incyte Corporation (INCY)

78.45   0.4 (0.51%) 02-14 16:00
Open: 78.01 Pre. Close: 78.05
High: 78.46 Low: 77.4513
Volume: 1,370,174 Market Cap: 17006M
Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 78.557 - 78.848 78.848 - 79.082
Low: 76.655 - 77.026 77.026 - 77.324
Close: 77.893 - 78.466 78.466 - 78.926

Technical analysis

as of: 2020-02-14 4:29:51 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 96.22     One year: 112.38
Support: Support1: 75.87    Support2: 71.84
Resistance: Resistance1: 82.38    Resistance2: 96.22
Pivot: 75.34
Moving Average: MA(5): 76.72     MA(20): 76.13
MA(100): 82.32     MA(250): 81.91
MACD: MACD(12,26): -1.32     Signal(9): -2.12
Stochastic oscillator: %K(14,3): 77.61     %D(3): 64.45
RSI: RSI(14): 52.39
52-week: High: 96.79  Low: 71.84  Change(%): -6.7
Average Vol(K): 3-Month: 152761  10-Days: 126009

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
INCY has closed below upper band by 2.3%. Bollinger Bands are 34.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2020-02-13
Incyte Stock Is Rising After the Drug Company Reports a ‘Solid Quarter and Guidance’
Incyte reported non-GAAP diluted earnings of 65 cents per share for the fourth quarter of 2019 and revenue of $579.4 million. Sales of Jakafi, a blood-cancer treatment that is the company’s key product, were $466 million.

2020-02-13
Earnings Scheduled For February 13, 2020
Companies Reporting Before The Bell The Kraft Heinz Company (NASDAQ: KHC ) is estimated to report quarterly earnings at $0.68 per share on revenue of $6.61 billion. PepsiCo, Inc. (NASDAQ: PEP ) is expected to report quarterly earnings at $1.44 per share on revenue of $20.27 billion. Waste Management, Inc. (NYSE: WM ) is projected to report quarterly earnings at $1.15 per share on revenue of $3.97 billion. Huntington Ingalls Industries, Inc. (NYSE: HII ) is expected to report quarterly earnings at $4.20 per share on revenue of $2.32 billion. Alibaba Group Holding Limited (NYSE: BABA ) is projected to report quarterly earnings at $2.22 per share on revenue of $22.45 billion. American International Group, Inc. (NYSE: AIG ) is estimated to report quarterly earnings at $1.00 per share on revenue of $11.90 billion. Fidelity National Information Services, Inc. (NYSE: FIS ) is projected to report quarterly earnings at $1.53 per share on revenue of $3.33 billion. Zoetis Inc. (NYSE: ZTS ) is expected to report quarterly earnings at $0.88 per share on revenue of $1.00 billion.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 215.40
Shares Float (M) 181.75
% Held by Insiders 0.62
% Held by Institutions 96.29
Shares Short (K) 4620
Shares Short P. Month (K)

Stock Financials

EPS 1.870
Book Value (p.s.) 11.250
PEG Ratio 0.52
Profit Margin 19.21
Operating Margin 19.57
Return on Assets (ttm) 9.0
Return on Equity (ttm) 19.2
Qtrly Rev. Growth 22.7
Gross Profit (p.s.) 2.738
Sales Per Share
EBITDA (p.s.) 2.168
Qtrly Earnings Growth 339.60
Operating Cash Flow (M) 662.88
Levered Free Cash Flow (M) 431.21

Stock Valuations

P/E 41.95
P/E Growth Ratio 0.01
P/BV 6.97
P/S 7.97
P/CF 25.49

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio 2
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.